| Trial Identifier: | D8532C00002 |
| Sponsor: | AstraZeneca |
| Start Date: | February 2023 |
| Primary Completion Date: | February 2024 |
| Study Completion Date: | February 2024 |
| Condition: | Liver, Pancreas & Gallbladder - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Bulgarian Translation | |
| Spanish (United States) Translation | |
| Slovak Translation |
| Country | Location |
|---|---|
| BG | Sofia, BG, 1612 |
| SK | Bratislava, SK, 831 01 |
| US, CA | Rialto, CA, US, 92377 |
| US, TX | San Antonio, TX, US, 78229 |
| US, TX | San Antonio, TX, US, 78215 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company